Is Hereditary multiple exostoses hereditary?

Hereditary multiple exostoses (HME) is a genetic condition inherited in an autosomal dominant pattern, meaning an affected individual has a 50% chance of passing the condition to each of their children. While it is strongly hereditary, approximately 10% to 20% of cases arise from de novo (spontaneous) mutations, occurring in individuals with no prior family history of the disorder.

Is Hereditary multiple exostoses considered a hereditary condition?

Yes, Hereditary multiple exostoses is a genetic disorder characterized by the growth of multiple benign bone tumors (osteochondromas). Because it is caused by mutations in specific genes—most commonly EXT1 or EXT2—it is considered a hereditary condition. In an autosomal dominant inheritance pattern, only one copy of the altered gene in each cell is sufficient to cause the disorder. When a parent has Hereditary multiple exostoses, there is a 50% statistical probability that each pregnancy will inherit the pathogenic variant, regardless of the child's sex.

What are the roles of de novo mutations and genetic testing?

While Hereditary multiple exostoses is typically passed down through families, it can also occur sporadically. A de novo mutation means the genetic change occurred for the first time in the affected individual, often during the formation of reproductive cells or early embryonic development. Genetic testing is highly effective for confirming a diagnosis of Hereditary multiple exostoses. Molecular genetic testing identifies pathogenic variants in the EXT1 (approximately 60–70% of cases) or EXT2 (approximately 30% of cases) genes. Testing is recommended to confirm the clinical diagnosis, provide accurate recurrence risk assessments for family planning, and guide long-term clinical monitoring.

Why is genetic counseling recommended for families?

Genetic counseling is a vital step for families navigating Hereditary multiple exostoses, as it provides a space to discuss the implications of the diagnosis, the nature of autosomal dominant inheritance, and options for family planning. Counselors help families understand the high variability in clinical expression, even among family members with the same genetic mutation. For those planning pregnancies, options such as preimplantation genetic testing (PGT) or prenatal diagnosis may be discussed depending on the family's values and specific genetic findings.

Key facts about the genetics of Hereditary multiple exostoses

• Inheritance Pattern: Autosomal dominant.


• Primary Genes Involved: EXT1 (located on chromosome 8) and EXT2 (located on chromosome 11).


• Recurrence Risk: 50% for each child of an affected parent.


• Spontaneous Rate: 10–20% of cases are estimated to be de novo mutations.


• Clinical Variability: Symptoms and the number of exostoses can vary significantly, even within the same family.

Our DiseaseMaps.org community includes 266 people with Hereditary multiple exostoses who share their lived experiences, providing a supportive network for those managing this condition.

Next steps

• Consult with a clinical geneticist to discuss molecular testing and family screening.


• Request a referral to an orthopedic specialist experienced in managing skeletal dysplasias.


• Connect with the 266 members of our DiseaseMaps.org community to share support and resources.


• Maintain a consistent schedule of imaging and clinical evaluations to monitor for potential complications, such as malignant transformation.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always consult with your physician regarding your specific health needs.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD): Hereditary multiple exostoses.


• Orphanet: Multiple osteochondromas.


• Online Mendelian Inheritance in Man (OMIM): Entry #133700 (EXT1) and #133701 (EXT2).


• The MHE Research Foundation: Resources for patients and families.